Oncology Cytogenetics Diagnostic Service - User Guide 2014

Similar documents
Your single-source laboratory solution. FISH Probe Library

KHMDC Oncology Cytogenetics User Guide

TEST MENU TEST CPT CODES TAT. Chromosome Analysis Bone Marrow x 2, 88264, x 3, Days

CYTOGENETICS INTRODUCTION SPECIAL INSTRUCTIONS ON SAMPLE COLLECTION AND HANDLING

molecular oncology services

KREATECH DIAGNOSTICS SOLID TUMORS

Molecular Diagnosis. Nucleic acid based testing in Oncology

Nucleic Acid Testing - Oncology. Molecular Diagnosis. Gain/Loss of Nucleic Acid. Objectives. MYCN and Neuroblastoma. Molecular Diagnosis

September 04, 2008

HEMATOPATHOLOGY SERVICES

The Power of Observation

Outline. Chromosomal analysis FISH. Chromosomal abnormalities in cancer. Clinical application of cytogenetics. Procedure Nomenclature

Significance of Chromosome Changes in Hematological Disorders and Solid Tumors

Significance of Chromosome Changes in Hematological Disorders and Solid Tumors

GENETICS OF HEMATOLOGICAL MALIGNANCIES

Molecular pathology/genetics of sarcomas

Genetic Testing Oncology

Combinations of morphology codes of haematological malignancies (HM) referring to the same tumour or to a potential transformation

Klinisch belang van chromosomale translocatie detectie in sarcomen

Molecular. Oncology & Pathology. Diagnostic, Prognostic, Therapeutic, and Predisposition Tests in Precision Medicine. Liquid Biopsy.

Objectives. Morphology and IHC. Flow and Cyto FISH. Testing for Heme Malignancies 3/20/2013

XCyting DNA FISH Probes

DNA-FISH Probe Catalog Empowering Personalized Cancer Treatment.

2010 Hematopoietic and Lymphoid ICD-O Codes - Alphabetical List THIS TABLE REPLACES ALL ICD-O-3 Codes

2012 Hematopoietic and Lymphoid ICD-O Codes - Numerical List THIS TABLE REPLACES ALL ICD-O-3 Codes

a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation

ZytoLight SPEC FGF3,4,19/CEN 11 Dual Color Probe

Molecular Genetics of Paediatric Tumours. Gino Somers MBBS, BMedSci, PhD, FRCPA Pathologist-in-Chief Hospital for Sick Children, Toronto, ON, CANADA

Cost-Effective Strategies in the Workup of Hematologic Neoplasm. Karl S. Theil, Claudiu V. Cotta Cleveland Clinic

Celebrating 20 years of the Database Joint UKCCG and CHO Annual Conference. 22 nd -23 rd March 2012 Newcastle upon Tyne

Chapter 2 Classical and Molecular Cytogenetic Analysis of Hematolymphoid Disorders

Disclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction

Recommended Timing for Transplant Consultation

Supplementary Appendix

Introduction to Cytogenetics

Molecular pathology in soft tissue tumors. Sylvia Höller Pathologie

Out-Patient Billing CPT Codes

Use of MYC, BCL2 and BCL6 FISH for investigations of high grade B cell lymphoma

Molecular Hematopathology

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Tumor Cytogenetics. Department of Pathology & Cell Biology & Institute for Cancer Genetics. Vundavalli Murty. Sept 24, 2017

Hematology Diagnostic Services

Recent advances in the genetics & biology of lymphoma

Case #1. 65 yo man with no prior history presented with leukocytosis and circulating blasts: Bone marrow biopsy was performed

Disclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction

Introduction: The Revised (4 th Edition) World Health Organization (WHO) Classification of Tumors of Hematopoietic and Lymphoid Tissues

HOW MAY THE CLASSIFICATION OF SOFT TISSUE TUMORS EVOLVE?

Clinical Validation of Cytocell Pathology Probes

Addressing the challenges of genomic characterization of hematologic malignancies using microarrays

Original Articles. Utilization of Fluorescence In Situ Hybridization in the Diagnosis of 230 Mesenchymal Neoplasms. An Institutional Experience

HEMATOPATHOLOGY DIAGNOSIS & SUBTYPING. Use of IHC. Use of Polymerase Chain Reaction (PCR) Use of Flow Cytometry

Cytogenetics Update. Lynda J Campbell

Lab Guide 2018 Diagnostic Genomic Division(DGD)

PhenoPath. Diagnoses you can count on B CELL NON-HODGKIN LYMPHOMA

Fluorescence In Situ Hybridization in the Diagnosis of Soft Tissue Neoplasms: A Review. Munir R. Tanas, MD and John R.

Treatments and Current Research in Leukemia. Richard A. Larson, MD University of Chicago

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Clinical utility of FISH analysis in addition to G-banded karyotype in hematologic malignancies and proposal of a practical approach

NeoTYPE Cancer Profiles

Appendix 6: Indications for adult allogeneic bone marrow transplant in New Zealand

Clinical Cytogenetic Services

Bone Marrow Processing Overview Document Reference: LP-SI-HMDS_BM Processing Overview

Corrigenda. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (revised 4th edition): corrections made in second print run

Role of FISH in Hematological Cancers

Krishna Reddy CH and Ashwin Dalal. Diagnostics Division, Centre for DNA Fingerprinting and Diagnostics, Hyderabad

Clinical Cytogenomics Laboratory. Laboratory. Leading diagnostics for better medicine. Beaumont

Oxford BRC Haemato-Molecular Diagnostic Service

Financial disclosures

West Midlands Regional Genetics Laboratory

Reporting cytogenetics Can it make sense? Daniel Weisdorf MD University of Minnesota

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport

Classification of Hematologic Malignancies. Patricia Aoun MD MPH

NeoTYPE Cancer Profiles

Diagnostic Molecular Pathology of Myeloid Neoplasms

Molecular Markers in Acute Leukemia. Dr Muhd Zanapiah Zakaria Hospital Ampang

Test Name Results Units Bio. Ref. Interval. Positive

Relapse Cytogenetics Overview of ALLR3 genetics Introduction to the IntReALL trial. Anthony V Moorman Leukaemia Research Cytogenetics Group

35 th UKCCG Meeting. Joint UKCCG and CHO Annual Conference. 9 th 10 th April 2013 Newcastle upon Tyne

Eosinophilia: A Diagnostic Approach and Test Utilization Strategies for Bone Marrow Evaluation

Differential diagnosis of hematolymphoid tumors composed of medium-sized cells. Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital

Journal of Solid Tumors, April 2012, Vol. 2, No. 2

Initial Diagnosis and Treatment 81 Male

WHO Classification of Myeloid Neoplasms with Defined Molecular Abnormalities

Surgical Pathology Evening Specialty Conference USCAP 2015

Fluorescence in-situ Hybridization (FISH) ETO(RUNX1T1)/AML1(RUNX1) or t(8;21)(q21.3;q22)

The role of cytogenomics in the diagnostic work-up of Chronic Lymphocytic Leukaemia

Particolarità molecolari delle neoplasie sarcomatose: Quale lezione biologica possiamo trarre per tutte le altre neoplasie?

Molecular Pathogenesis of Multiple Myeloma:

Case Workshop of Society for Hematopathology and European Association for Haematopathology

August 17, Dear Valued Client:

Molecular Markers. Marcie Riches, MD, MS Associate Professor University of North Carolina Scientific Director, Infection and Immune Reconstitution WC

Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms. Daniel A. Arber, MD Stanford University

Haematology Probes for Multiple Myeloma

The Challenges of Precision Medicine: New Advances in Molecular Diagnostic Testing- Impact for Healthcare

Oncology Genetics: Cytogenetics and FISH 17/09/2014

Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?

Cutaneous Mesenchymal Neoplasms with EWSR1 Rearrangement

Transcription:

Oncology Cytogenetics Diagnostic Service - User Guide 2014 Contact details Address: Cytogenetics Department 5 th Floor Tower Wing Guy s Hospital Great Maze Pond London SE1 9RT General enquiries 0207 188 1709 Fax 0207 188 1697 Hours of Operation Monday to Friday 9.00am to 5.30pm Weekends/Bank Holidays There is no service at weekends or bank holidays. Samples requiring urgent processing or analysis at these times should be discussed in advance. CONTROLLED DOCUMENT Page 1 of 12

B-cell acute lymphoblastic leukaemia G-banded karyotype FISH tests: Probe BCR-ABL TEL-AML1 (ETV6-RUNX1) MLL MLL/AFF1 TCF3(E2A) PAX5 ETV6 CDKN2A(9p21)/CEP9 Abnormality t(9;22) t(12;21) 11q23 t(4;11) t(1;19)/ t(17;19) dic(9;12) dic(9;12) del(9p) CONTROLLED DOCUMENT Page 2 of 12

T-cell acute lymphoblastic leukaemia (T- ALL) T-cell prolymphocytic leukaemia (T-PLL) G-banded karyotype FISH tests: Probe Abnormality Disease BCR-ABL NUP214/ABL T-ALL MLL t(11q23;) ATM del(11q22.3) T-PLL TCL1 inv(14) T-PLL TCRαδ t/inv(14q11;?) T-ALL/ T-PLL TCRβ t(7q34;?) T-ALL TCRγ t(7p14;?) T-ALL TLX3(HOX11L2) t(5;14) T-ALL TLX1(HOX11) t(10q24;?) T-ALL SIL-TAL1 del(1p32)/ t(1;14) T-ALL T-ALL FISH testing strategy: CONTROLLED DOCUMENT Page 3 of 12

NORMAL: No further tests TCL1 TLX1 TLX3 SIL-TAL1 BCR-ABL ABNORMAL (TCL1, TLX1 or TLX3) TCRαδ TCRβ TCRγ Acute Myeloid Leukaemia (AML)/ Myelodysplastic syndrome (MDS) G-banded karyotype FISH tests: Probe AML1-ETO PML-RARα RARα CBFβ MLL D5S23,D5S721/ EGR1 D7S486/CEP7 D20S108 Abnormality t(8;21) t(15;17) t(17;?) inv(16)/t(16;1 6) 11q23 del(5q31)/-5 del(7q31)/-7 del(20q) CONTROLLED DOCUMENT Page 4 of 12

Chromosome 8 Alpha satellite ETV6(TEL) EVI PDGFRβ Trisomy 8 t(12p13;?) inv(3)/t(3;3) 5q33 CONTROLLED DOCUMENT Page 5 of 12

Myeloproliferative neoplasms (MPN/CML) G-banded karyotype FISH tests: Probe Abnormality Disease BCR-ABL t(9;22)/var/cryptic/ CML del der(9) 4q21 tricolour Cryptic 4q12 deletion Hypereosinophilic syndrome (HES)/Chronic eosinophilic leukaemia (CEL) PDGFRβ 5q33 MDS/MPD FGFR1 t(8p11;?) 8p11 myeloproliferative syndrome CONTROLLED DOCUMENT Page 6 of 12

Chronic Lymphocytic Leukaemia (CLL) Interphase FISH analysis only: Probe TP53/ATM DLEU(13q14)/ LAMP/CEP12 Abnormality del(17p13)/ del(11q22.3) del(13q)/ trisomy 12 CONTROLLED DOCUMENT Page 7 of 12

Non-Hodgkin s Lymphoma (NHL) G-banded karyotype when bone marrow is infiltrated FISH testing can be carried out on FFPE tissue sections FISH tests: Probe Abnormality Disease IGH-MYC t(8;14) High grade B- cell NHL IGK t(2p11;?) High grade B- cell NHL IGL t(22q11;?) High grade B- cell NHL IGH t(14q32;) Non-specific IGH-CCND1 t(11;14) Mantle cell IGH-BCL2 t(14;18) Follicular/ High grade B-cell NHL ALK t(2;?) Anaplastic LCL BCL6 t(3q27;?) High grade B- cell NHL MALT1 t(18q21;?) MALT/MZL IGH-MALT1 t(14;18) MALT/MZL BIRC3 t(11;18) MALT/MZL (API2)-MALT1 BCL10 t(1p22;?) MALT/MZL PAX5 t(9p13;?) B-cell NHL MYC t(8q24;?)/ amplification High grade B- cell NHL BCL3 t(19q13) B-cell NHL CONTROLLED DOCUMENT Page 8 of 12

Interphase FISH analysis: Multiple Myeloma (MM) Probe CKS1B/CDKN2C TP53/ATM DLEU/ LAMP/CEP12 IGH IGH-FGFR3 IGH-CCND1 IGH-MAF IGH-MAFB IGH-CCND3 D5S23,D5S721/ CEP9/CEP15 Abnormality 1q21 gain 1p32 deletion del(17p) del(13q)/-13 t(14;?) t(4;14) t(11;14) t(14;16) t(14;20) t(6;14) Hyperdiploidy FISH testing strategy: CONTROLLED DOCUMENT Page 9 of 12

Breast cancer FISH analysis of FFPE tissue sections for HER2 status CONTROLLED DOCUMENT Page 10 of 12

Urothelial cancer FISH analysis of ThinPrep slides using the UroVysion FISH assay CONTROLLED DOCUMENT Page 11 of 12

Other solid tumours FISH tests (testing can be carried out on FFPE tissue sections): FISH probe Abnormality Tumour type HER2 Amplification Breast SYT t(18q11;) Synovial sarcoma FUS CHOP (DDIT3) t(16p11;) t(12q13;) FKHR (FOXO1A) t(13q14;) Myxoid liposarcoma (FUS/CHOP) Angiomatoid fibrous histiocytoma (FUS/ATF1) Fibromyxoid sarcoma, low grade (FUS/CREB3L2) Alveolar rhabdomyosarcoma EWS t(22q12;) Ewings sarcoma/primitive neuroectodermal tumour Desmoplastic small round cell tumour (with WT1 @ 11p13) Myxoid liposarcoma (with CHOP @ 12q13) Myxoid chondrosarcoma (with NOR1 @ 9q22) Clear cell sarcoma (with ATF1 @ 12q13) ALK t(2p23;) Inflammatory myofibroblastic tumour Non-small cell lung cancer ROS1 t(6q22;) Non-small cell lung cancer CONTROLLED DOCUMENT Page 12 of 12